Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Genitourinary Cancers
Do you recommend ADT for a high risk prostate cancer patient who had SBRT?
If so, how long?
Answer from: Radiation Oncologist at Community Practice
SBRT doesn’t mitigate benefit of ADT and the type and duration have to be the same as with EBRT or EBRT plus brachytherapy.
Comments
Radiation Oncologist at Genesis Healthcare Partners- San Diego
Since ADT has no benefit in high risk prostate ca ...
Radiation Oncologist at Varian Medical Systems/Allegheny health network
Ma et al., PMID 35934601 This article highlight...
6993
6998
Sign in or Register to read more
Answer from: Radiation Oncologist at Academic Institution
I would not treat a high risk patient with SBRT.
Sign in or Register to read more
14207
14233
Related Questions
How do you design pelvic lymph node treatment volumes for patients with tortuous or aberrant vascular anatomy?
Why is there a benefit of ADT for high risk prostate cancer treated with radiation, yet no large trials describing benefit of adjuvant ADT after radical prostatectomy?
What are your top takeaways from ASCO GU 2025?
Does long term use of 5 alpha reductase inhibitors change the way you evaluate a PSMA PET?
How would you approach de novo metastatic castrate sensitive prostate cancer with extensive locoregional spread causing rectal compression, retroperitoneal lymphadenopathy, and PSA >3000 but no visceral or bone metastases?
What urethral dose constraints would you use off-trial for reirradiating the prostate using SBRT?
How do you approach treatment for a patient with an isolated perineal/pubic recurrence of penile SCC s/p definitive surgery?
Is there any evidence for amyloid/amyloidosis causing a spurious/false PSA reading?
Would you ever omit or reduce prostate bed radiation in a post-prostatectomy patient who develops recurrence in pelvic LNs?
How are you integrating Prostox into your practice for prostate patients deciding between SBRT and hypofractionation?
Since ADT has no benefit in high risk prostate ca ...
Ma et al., PMID 35934601 This article highlight...